search again

Melanoma Versus Benign Mole Gene Test

Nationwide rates for HCPCS 0314U

Helps decide whether a skin lesion is a melanoma or a harmless mole when its appearance under the microscope is not clear cut. The activity of 35 genes is measured in the stored tissue sample and the lesion is classified accordingly. A companion test instead judges the outlook for squamous cell skin cancers.

Rates data updated July 2026.

Facilitymedian $2,818 · 10th–90th $1,549$8,1280%10%20%10th90th$2,818Professionalmedian $1,622 · 10th–90th $1,072$2,9510%20%10th90th$1,622$2.0$10.0$50.0$200.0$1.0K$5.0K$20.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$1,548.82
Median
$3,019.95
Typical High
$8,128.31
Aetna
Setting
Professional
Modifier
Global
Typical Low
$1,174.90
Median
$1,548.82
Typical High
$2,187.76
BCBS
Setting
Facility
Modifier
Global
Typical Low
$1,949.84
Median
$3,801.89
Typical High
$9,332.54
BCBS
Setting
Professional
Modifier
Global
Typical Low
$1,380.38
Median
$1,548.82
Typical High
$3,235.94
Cigna
Setting
Facility
Modifier
Global
Typical Low
$1,318.26
Median
$3,630.78
Typical High
$8,511.38
Cigna
Setting
Professional
Modifier
Global
Typical Low
$2,238.72
Median
$2,818.38
Typical High
$5,754.40
United
Setting
Facility
Modifier
Global
Typical Low
$1,174.90
Median
$1,949.84
Typical High
$2,344.23
United
Setting
Professional
Modifier
Global
Typical Low
$812.83
Median
$1,174.90
Typical High
$2,398.83